Sort   by:  
 Page size 
UnknownTafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study.
Not available
S-EPMC10797539 | biostudies-literature
UnknownAnalysis of tumour- and stroma-supplied proteolytic networks reveals a brain-metastasis-promoting role for cathepsin S.
Not available
S-EPMC4249762 | biostudies-literature
UnknownIKZF2 Drives Leukemia Stem Cell Self-Renewal and Inhibits Myeloid Differentiation.
Not available
S-EPMC6602096 | biostudies-literature
UnknownSafety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma.
Not available
S-EPMC10183830 | biostudies-literature
UnknownOutcomes of tafasitamab and lenalidomide in large B-cell lymphoma based on prior CD19-directed CAR T exposure.
Not available
S-EPMC12626236 | biostudies-literature
UnknownARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer.
Not available
S-EPMC7341683 | biostudies-literature
UnknownTreatment Effectiveness of Venetoclax-Based Therapy After Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real-World Study.
Not available
S-EPMC11803543 | biostudies-literature
UnknownFunctional screen of MSI2 interactors identifies an essential role for SYNCRIP in myeloid leukemia stem cells.
Not available
S-EPMC5508533 | biostudies-literature
UnknownCOVID-19 in patients with CLL: improved survival outcomes and update on management strategies.
Not available
S-EPMC8313815 | biostudies-literature
UnknownAssociation of germline variation with the survival of women with <i>BRCA1/2</i> pathogenic variants and breast cancer.
Not available
S-EPMC7483417 | biostudies-literature
Sort   by:  
 Page size